Gsk have released new phase III data
Placebo -4.9 ± 7.89
0.02mg dut 17.1 ± 7.74
0.1mg dut 63.0 ± 7.67
0.5mg dut 89.6 ± 7.87
1mg fin - 56.5 ± 8.12
Placebo -4.9 ± 7.89
0.02mg dut 17.1 ± 7.74
0.1mg dut 63.0 ± 7.67
0.5mg dut 89.6 ± 7.87
1mg fin - 56.5 ± 8.12
Comment